PLAVIX DIN 02238682
Status: Marketed
Holder: SANOFI-AVENTIS CANADA INC
Molecule: CLOPIDOGREL (CLOPIDOGREL BISULFATE)
Available to quote
Health Canada record
| Active ingredient(s) | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | B01AC04 CLOPIDOGREL |
| Original market date | 13-Oct-1998 |
| Current status date | 10-Apr-2007 |
| Source | Health Canada DPD |
Establishment licence of the holder
sanofi-aventis Canada Inc. — licence 101470, currently licensed, last inspection rating C (2026-02-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CLOPIDOGREL (CLOPIDOGREL BISULFATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02431971 | AG-CLOPIDOGREL | ANGITA PHARMA INC. | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Marketed |
| 02570505 | ALTA-CLOPIDOGREL | ALTAMED PHARMA | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 300 MG | Approved |
| 02570491 | ALTA-CLOPIDOGREL | ALTAMED PHARMA | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Approved |
| 02252767 | APO-CLOPIDOGREL | APOTEX INC | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Marketed |
| 02398591 | APO-CLOPIDOGREL | APOTEX INC | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 300 MG | Marketed |
| 02416387 | AURO-CLOPIDOGREL | AURO PHARMA INC | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Marketed |
| 02444895 | BIO-CLOPIDOGREL | BIOMED PHARMA | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Marketed |
| 02540177 | BIO-CLOPIDOGREL | BIOMED PHARMA | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 300 MG | Approved |
| 02400553 | CLOPIDOGREL | SANIS HEALTH INC | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Marketed |
| 02394820 | CLOPIDOGREL | PRO DOC LIMITEE | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Marketed |
| 02385813 | CLOPIDOGREL | SIVEM PHARMACEUTICALS ULC | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Marketed |
| 02420805 | IPG-CLOPIDOGREL | MARCAN PHARMACEUTICALS INC | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 300 MG | Approved |
| 02420791 | IPG-CLOPIDOGREL | MARCAN PHARMACEUTICALS INC | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Approved |
| 02415550 | JAMP-CLOPIDOGREL | JAMP PHARMA CORPORATION | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Marketed |
| 02502283 | M-CLOPIDOGREL | MANTRA PHARMA INC | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Marketed |
| 02502291 | M-CLOPIDOGREL | MANTRA PHARMA INC | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 300 MG | Approved |
| 02422263 | MAR-CLOPIDOGREL | MARCAN PHARMACEUTICALS INC | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 300 MG | Approved |
| 02422255 | MAR-CLOPIDOGREL | MARCAN PHARMACEUTICALS INC | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Marketed |
| 02408910 | MINT-CLOPIDOGREL | MINT PHARMACEUTICALS INC | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Marketed |
| 02408929 | MINT-CLOPIDOGREL | MINT PHARMACEUTICALS INC | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 300 MG | Approved |
| 02482045 | NRA-CLOPIDOGREL | NORA PHARMA INC | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 300 MG | Approved |
| 02482037 | NRA-CLOPIDOGREL | NORA PHARMA INC | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Marketed |
| 02348004 | PMS-CLOPIDOGREL | PHARMASCIENCE INC | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Marketed |
| 02392755 | RBX-CLOPIDOGREL | SUN PHARMA CANADA INC | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Approved |
| 02388529 | RIVA-CLOPIDOGREL | LABORATOIRE RIVA INC. | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Marketed |
| 02379813 | TARO-CLOPIDOGREL | SUN PHARMA CANADA INC | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Marketed |
| 02388065 | TEVA-CLOPIDOGREL | TEVA CANADA LIMITED | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 300 MG | Marketed |
| 02293161 | TEVA-CLOPIDOGREL | TEVA CANADA LIMITED | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Marketed |
| 02412942 | ABBOTT-CLOPIDOGREL | ABBOTT LABORATORIES, LIMITED | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Cancelled Post Market |
| 02419963 | ACCEL-CLOPIDOGREL | ACCEL PHARMA INC | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Cancelled Post Market |
| 02419971 | ACCEL-CLOPIDOGREL | ACCEL PHARMA INC | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 300 MG | Cancelled Pre Market |
| 02303027 | ACT CLOPIDOGREL | TEVA CANADA LIMITED | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Cancelled Post Market |
| 02378507 | DOM-CLOPIDOGREL | DOMINION PHARMACAL | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Cancelled Post Market |
| 02351536 | MYLAN-CLOPIDOGREL | MYLAN PHARMACEUTICALS ULC | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Cancelled Post Market |
| 02423820 | MYLAN-CLOPIDOGREL | MYLAN PHARMACEUTICALS ULC | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 300 MG | Cancelled Pre Market |
| 02330555 | PLAVIX | SANOFI-AVENTIS CANADA INC | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 300 MG | Cancelled Post Market |
| 02445336 | PRIVA-CLOPIDOGREL | PHARMAPAR INC | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Cancelled Post Market |
| 02375583 | Q-CLOPIDOGREL | QD PHARMACEUTICALS ULC | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Cancelled Pre Market |
| 02359316 | SANDOZ CLOPIDOGREL | SANDOZ CANADA INCORPORATED | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Cancelled Post Market |
| 02394928 | TORRENT-CLOPIDOGREL | TORRENT PHARMACEUTICALS LIMITED | Tablet | CLOPIDOGREL (CLOPIDOGREL BISULFATE) 75 MG | Cancelled (Unreturned Annual) |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 7858 | 2006-03-29 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 1027 | 2000-11-28 | New Drug Submission (NDS) | |
| 2748 | 1998-10-07 | New Drug Submission (NDS) |